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Abstract: Background: Menopause is associated with important systemic and oral changes. Many researchers have 
tried to evaluate the influence of hormonal changes associated with menopause in the periodontium, however re-
sults are contradictory. Objective: Evaluate the possible effects of menopause on the severity of periodontal disease 
and tooth loss, by considering several general, oral and periodontal parameters. Methods: 102 women with chronic 
periodontitis, and at least six teeth, were divided into two groups: a study group (SG) consisting of 68 menopausal 
women and a control group (CG) consisting of 34 premenopausal women. The participants had extensive anamne-
sis, made by a single senior periodontologist, which collected demographic data, medical and gynaecological history 
and habits. Additionally, oral and periodontal parameters including: number of teeth, plaque index, presence of cal-
culi, probing depth, bleeding on probing, gingival recession and attachment loss were recorded. The following statis-
tical tests were used: Chi-square, Fisher’s t-test for independent samples, non-parametric Wilcoxon-Mann-Whitney, 
and linear multiple regression. Results: The number of teeth was significantly lower in postmenopausal women (SG 
10.8 ± 5.9, CG 6.8 ± 4.6), however, after adjusting for age, smoking and plaque index, the difference was no longer 
statistically significant (P=0.169). The attachment loss was slightly higher in the study group, although the differ-
ence is not significant (SG 4.31 ± 1.08, CG 4.05 ± 1.28). Conclusions: Menopause does not appear to significantly 
influence the severity of periodontal disease and tooth loss. Other factors may exert a greater influence on the pro-
gression of periodontal disease rather than menopause itself.
Keywords: Periodontal disease, menopause, osteoporosis, oestrogen
Introduction
Menopause period is increasing and is associ-
ated with important systemic and oral manifes-
tations [1, 2]. During menopause, gingival epi-
thelium becomes thinner, atrophic and more 
prone to inflammatory changes [3], on the other 
hand, salivary flow rate decreases and salivary 
composition may be altered, contributing to the 
development of several oral conditions [4].
The sudden decrease in oestrogen production 
that occurs in menopause is considered to be 
the main cause of primary osteoporosis, which 
also affects jawbones [5, 6]. It has been sug-
gested that this reduction in bone mineral den-
sity could contribute to periodontal disease 
progression [7].
Besides their effect on bone, estrogens also 
interfere with other periodontal tissues (gingiva 
and periodontal ligament) and influence host 
immune-inflammatory responses [8-10]. A num-
ber of studies have linked menopause with 
some periodontal conditions, although the dif-
ferent methods applied to define and assess 
osteoporosis, alveolar bone loss and periodon-
titis make it difficult to compare the results [11].
Several studies reported an improvement of the 
periodontal parameters [12], and tooth reten-
tion [13-15] in women undergoing hormone 
replacement therapy (HRT), however, contra-
dicting results have been published [16, 17]. 
Furthermore, drugs that alter bone metabolism, 
such as estrogen and bisphosphonates, were 
suggested by several case-control studies as a 
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new approach to the treatment of periodontitis 
in postmenopausal patients [18].
The aim of this study was to evaluate the pos-
sible effects of menopause on the severity of 
periodontal disease and tooth loss, by consid-
ering several general, oral and periodontal 
parameters, in two groups of women with peri-
odontitis (pre and postmenopausal).
Patients and methods
Study design
This cross-sectional study was conducted at 
the University Clinic of the Egas Moniz Health 
Sciences Institute (Almada, Portugal). Approval 
from this institution’s ethics committee was 
obtained.
Women aged 35-80 years were selected, with 
at least 6 teeth present, diagnosis of chronic 
periodontitis and absence of periodontal treat-
ments in the last year. The following patients 
were excluded: women with diagnosis of ag- 
gressive periodontitis; women who refused to 
sign the informed consent form; women who 
were participating in other studies.
Of the 111 patients initially screened, 8 did not 
meet the inclusion criteria and 1 refused to par-
ticipate, resulting in a final sample of 102 par-
ticipants, who were divided according to meno-
pausal status in two groups: a study group, 
consisting of 68 postmenopausal women and a 
control group, consisting of 34 premenopausal 
women.
Women were considered in menopause, when 
they had absence of menstruation for more 
than 12 months, or had undergone a hysterec-
tomy with bilateral oophorectomy [19].
Concerning Periodontal Disease we used the 
criteria set by the working group of the Centres 
for Disease Control and Prevention (CDC) [20].
Study protocol
All participants had extensive anamnesis done 
by a single senior periodontologist, covering: 
demographics, medical history, current medi-
cation, lifestyle habits (alcohol consumption, 
smoking, and exercise), dental history and oral 
hygiene habits. Additionally, gynaecological his-
tory was collected in order to determine the 
level of hormone exposure (age at menarche, 
number of pregnancies, number of births, age 
at menopause and use of oral contraceptives 
or hormone replacement therapy for more than 
6 months).
Oral and periodontal examination
A single senior periodontologist, blinded to the 
groups, conducted all measurements. Before 
the study, this examiner was evaluated by 
another experienced clinician, according to the 
method proposed by Altman & Bland [21]. A 
high level of agreement for measurements of 
probing depth and gingival recession was found 
(concordance in 90%; difference ≤ 1 mm). The 
screening was performed on 10 volunteer 
patients, 15 days before the beginning of the 
study.
Concerning oral evaluation, World Health Org- 
anization, decayed, missing and filled teeth 
index (DMFT) [22] was calculated. Additionally, 
the presence of fixed or removable prostheses 
was also recorded.
Periodontal evaluation considered all com-
pletely erupted teeth, excluding third molars, 
retained roots and implants. The examination 
began by assessing the presence of supragingi-
val calculus (absent/present) and determina-
tion of plaque index (Simplified Plaque Index) 
[23].
The probing depth (PD) and gingival recession 
(REC) were evaluated at six sites per tooth 
using a CP-12 graduated periodontal probe 
(Hu-Friedy®, Chicago, IL, USA). Simultaneously, 
locations with bleeding on probing after 10 sec-
onds (BOP) were recorded. Clinical attachment 
level (CAL) was calculated by adding PD to REC. 
In addition, furcation defects were evaluated in 
molars and mobility was evaluated in all teeth.
Statistical analysis
Prior to analysis, all data were screened for 
accuracy and completeness. Data were entered 
into a Microsoft Office Excel 2003® (Microsoft, 
Seattle, USA) database. The Statistical Package 
for Social Sciences 17 (SPSS, Chicago, USA) 
was used for the statistical analysis.
Analyses were performed on a subject basis. 
Descriptive statistics for all variables were con-
ducted, including: means, standard deviations, 
ranges and percentages.
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For qualitative variables (nominal and ordinal), 
Chi-square test and Fisher's exact test were 
used. For quantitative variables (discrete or 
continuous) nonparametric Wilcoxon-Mann-
Whitney and t test for independent samples 
were used. For some variables, linear multiple 
regression analysis were performed in order to 
control the effect of possible confounding 
factors.
A significance level of α=0.05 was set for all 
tests (P < 0.05).
Results
The general characteristics of the study popula-
tion are summarized in Table 1. The majority of 
the women are Caucasian (92.2%), overweight 
or obese (SG 70.6%, CG 52.9%; no significant 
differences in body mass index between 
groups) and, as expected, the average age in 
the study group is higher than in the control 
group (61.2 ± 8.0 vs. 44.8 ± 5.2). Smokers and 
former smokers in the control group are almost 
twice than in the study group (SG 27.9%, CG 
Table 1. General characteristics of the study population (n=102)
Study group (n=68) Control group (n=34) P-value
Average (SD) or n (%)
Age 61.2 (8.1) 44.8 (5.2) t (92.9)=12.37; P < 0.001
Education level Χ2 (1)=13.45; P < 0.001
    Elementary 51 (75.0%) 13 (38.2%)
    Secondary 9 (13.2%) 13 (38.2%)
    Higher 8 (11.8%) 8 (23.5%)
Race F ns
    Caucasian 63 (92.6%) 31 (91.2%)
    Black 5 (7.4%) 3 (8.8%)
BMI 27.8 (5.4) 26.2 (4.9) U=954.0; W=1549.0; ns
Tobacco consumption Χ2 (1)=10.88; P < 0.01
    Never 49 (72.1%) 13 (38.2%)
    Smokers or former smokers 19 (27.9%) 21 (61.8%)
Alcohol consumption Χ2 (1)=0.12; ns
    Never 14 (20.6%) 8 (23.5%)
    Current or previous 54 (79.4%) 26 (76.5%)
At least one dental visit in the last year 16 (23.5%) 12 (35.3%) Χ2 (1)=1.58; ns
BMI–Body mass index; F–Fisher test; ns–not significant; t–unpaired t-test; U, W–non-parametric Wilcoxon-Mann-Whitney test; 
Χ2–Chi-square test.
Table 2. Hormonal history 
Study group (n=68) Control group (n=34) P-value
average (SD) or n (%)
Age of menarche 12.8 ± 1.6 12.34 ± 1.70 U=858.0; W=1386.0; ns
Age of menopause 49.3 ± 5.6 ----- -----
No. of pregnancies 2.7 ± 1.8 2.4 ± 2.4 U=979.5; W=1574.5; ns
No. of births 1.8 ± 1.2 1.7 ± 1.1 U=1133.5; W=1728.5; ns
Years of oral contraceptive use 9.3 ± 10.2 10.6 ± 11.0 U=927.5; W=3205.5; ns
Reproductive years 36.7 ± 5.8 33.2 ± 5.8 t (99)=2.85; P < 0.01
Years of estrogen exposure 37.8 ± 6.0 9.0 ± 10.8 U=28.5; W=623.5; P < 0.001
Type of menopause ----- -----
    Physiological 57 (83.8%)
    Surgical 11 (16.2%)
HRT users 18 (26.5%) ----- -----
Years of HRT use 1.8±2.9 ----- -----
ns–not significant; t–unpaired t-test; U, W–non-parametric Wilcoxon-Mann-Whitney test.
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61.8%) and the number of packs/year is signifi-
cantly higher in the same group (SG 3.0 ± 8.3, 
CG 7.5 ± 10.7, P < 0.001). However, if we con-
sider non-smokers and former smokers togeth-
er the difference is less pronounced (SG 89.7%, 
CG 61.75%).
Concerning hormonal history (Table 2), the age 
of menarche is similar in both groups (SG 12.8, 
CG 12.3 years), and the mean age at meno-
pause was 49.3 ± 5.6 years. On average, 
women were in menopause for 11.8 years (SD 
9.4 yrs), and in 83.8% of cases menopause 
occurred naturally. Regarding pregnancies, 
births, and use of oral contraceptives no signifi-
cant differences were observed, although 
women in the study group used (on average) 
oral contraceptives for fewer years.
Regarding oral hygiene habits, frequency of 
dental visits and type of previous periodontal 
treatments, no differences were observed be- 
tween groups (Table 3).
In the study group the most commonly used 
drugs to treat/prevent osteoporosis were: bis-
amount of bacterial plaque is greater in the 
control group (P < 0.01), whereas the number 
of sextants with calculus is similar in both 
groups.
Gingival recession is slightly higher in the study 
group (SG 1.06 ± 0.81; CG 0.78 ± 0.70) and 
also attachment loss (SG 4.31 ± 1.08, CG 4.05 
± 1.28), although the difference is not signi- 
ficant.
Concerning the other periodontal parameters 
there are no differences between groups, ex- 
cept for a higher percentage of sites with PD > 
4 mm, in the control group (P < 0.05).
Discussion
The mechanisms that could explain the rela-
tionship between periodontal disease and 
menopause are not fully understood. Some 
studies have shown a relationship between 
decreased bone mineral density and tooth loss 
[24-26] and/or deterioration of certain perio-
dontal parameters [13, 24, 26], while others 
have failed to demonstrate such relationship 
[27, 28].





Average (SD) or n (%)
DMFT index 17.8 (6.9) 16.7 (5.5) t (100)=0.86; F ns
Last dental visit F ns
    ≤ 1 year 16 (23.5%) 12 (35.3%)
    > 1 year 52 (76.5%) 22 (64.7%)
Previous periodontal treatment
    None 43 (63.2%) 21 (61.8%) F ns
    Dental prophylaxis 19 (27.9%) 12 (35.3%) F ns
    Scaling and root planing --------- --------- -
    Periodontal surgery 1 (1.5%) --------- F ns
    Other 18 (26.5%) 4 (11.8%) F ns
Brushing F ns
    Once per day 14 (20.6%) 7 (20.6%)
    More than once per day 54 (79.4%) 27 (79.4%)
Flossing F ns
    Never/occasionally 61 (89.7%) 26 (76.5%)
    One or more times per day 7 (10.3%) 8 (23.5%)
Mouthwash use F ns
    Never/occasionally 38 (55.9%) 15 (44.1%)
    One or more times per day 30 (44.1%) 19 (55.9%)
DMF–Decayed Missing Filled index; F–Fisher test; ns–not significant; t–unpaired t-test; 
Χ2-Chi-square test.
phosphonates (11.7%), 
followed by HRT (4.4%). If 
we consider the previous 
use of HRT, the percent-
age increases to 26.5%. 
Only 4 women (5.9%) us- 
ed calcium supplements 
and none took vitamin D.
Postmenopausal women 
had fewer teeth than the 
premenopausal women 
(P < 0.01), but the reason 
for teeth loss was similar 
in both groups (Table 4). 
The major reason for 
tooth loss was the extrac-
tion in consequence of 
tooth decay (SG 48.5%, 
CG 58.8%). The number 
of teeth lost for periodon-
tal reasons was slightly 
higher in the study group, 
although the difference is 
not significant (SG 14.7%, 
CG 5.95%).
In relation to periodontal 
parameters (Table 5), the 
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In our study, nearly all women had at least one 
missing tooth, and the number of missing teeth 
was higher in the group of postmenopausal 
women (10.8 ± 5.9 vs. 6.8 ± 4.6; P < 0.01). The 
difference in the number of missing teeth (from 
all causes) observed in postmenopausal and 
premenopausal women could suggest a possi-
ble effect of menopause on tooth loss. However, 
it is conceivable that age, smoking and the 
accumulation of plaque may play a role as con-
founders on the relationship between meno-
pause and missing teeth. Multiple regression 
analysis is the best way to assess such rela-
tionship after adjusting for those confounders 
simultaneously [29].
Age is correlated with the number of missing 
teeth (P < 0.001) and smoking habits (P=0.005) 
and correlation is stronger with menopausal 
condition (P < 0.001), which is also associated 
with smoking (P=0.028). Multiple regression 
analysis shows that after adjustment for age, 
smoking and plaque index, the number of miss-
ing teeth is no longer influenced by menopau-
sal status (P=0.169). The quality of the fit was 
poor, as expressed by an adjusted R2 of 0.177, 
which means that factors other than those 
included in the model may play a role in tooth 
loss. Moreover, the multiple regression analy-
sis of the same data, after removing meno-
pause as a predictor, also shows that smoking, 
plaque index and age are significant predictors 
of missing teeth, with observed powers of 45.5, 
71.0 and 98.7%, respectively. 
The use of missing teeth as a surrogated meas-
ure of periodontal disease has several limita-
tions [30] because tooth loss is a complex phe-
nomenon and reflects cumulative conditions of 
oral health over time [31]. In a large prospec-
tive study , LaMonte et al. observed that perio-
dontal disease was responsible for 13% of 
Table 4. Comparison of the number of teeth in premenopausal and postmenopausal women
Study group (n=68) Control group (n=34) P-value
Subjects with missing teeth n (%) 66 (97.1%) 34 (100%) F ns
No. of missing teeth (average ± SD) 10.8 ± 5.9 6.8 ± 4.7 U=710.5; W=1035.5; P < 0.01
Reason for loss n (%)
    Periodontal 10 (14.7%) 2 (5.9%) F ns
    Decay 33 (48.5%) 20 (58.8%) F ns
    Fracture 3 (4.4%) 10 (29.0%) F ns
    Other 21 (30.9%) 10 (30.9%) F ns
    Unknown 1 (1.5%) 1 (2.9%) F ns
F–Fisher test; ns–not significant; U, W–non-parametric Wilcoxon-Mann-Whitney test.




(average ± SD) P-value
Plaque index 40.08 ± 20.24 51.41 ± 20.69 U=770.5; W=3116.5; P < 0.01
No. of sextants with calculus 2.38 ± 2.25 2.97 ± 2.59 U=1038.0; W=3384.0; ns
CAL 4.31 ± 1.08 4.05 ± 1.28 t (100)=1.09; ns
PD 3.25 ± 1.70 3.25 ± 0.69 U=1144.0; W=3490.0; ns
REC 1.06 ± 0.81 0.78 ± 0.70 U=875.5; W=1470.5,0; ns
Deepest pocket 7.1 ± 2.1 7.0 ± 1.6 U=1105,0; W=3451,5; ns
No. of locations PD ≥ 4 34.1 ± 20.8 45.7 ± 25.2 t (100)=-2,47; P < 0.05
No. of locations PD ≥ 6 9.3 ± 13.3 11.8 ± 11.9 U=941,0; W=3287,0; ns
No. of locations CAL ≥ 5 35.64 ± 21.62 33.92 ± 26.89 U=1050; W=1645; ns
No. of locations with BOP 37.75 ± 22.19 38.48 ± 22.76 t (100)=-0.16; ns
Tooth mobility 0.89 ± 0.59 0.75 ± 0.56 U=1124.5; W=1719.5; ns
Furcation lesions* 0.22 ± 0.58 0.17 ± 0.43 U=1128.0; W=1723.0; ns
*only for molars; CAL–clinical attachment loss; F–Fisher test; ns–not significant; PD–probing depth; REC–gingival recession; 
t–unpaired t-test; U, W–non-parametric Wilcoxon-Mann-Whitney test.
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teeth lost during a five-year follow-up period, 
although the mean number of teeth lost was 
quite small [32]. In our study, tooth loss due to 
periodontitis occurred in 14.7% of all patients, 
although some cases may have been included 
in the other/unknown category. It is important 
to note that differences at periodontal level 
between the two groups do not justify the dis-
crepancy in the number of missing teeth.
One of our inclusion criteria was the absence of 
periodontal treatment in the last year, in order 
to minimize potential differences caused by 
active therapy. As a matter of fact, only a minor-
ity of the women (37.3%) had ever had some 
kind of periodontal treatment, being these usu-
ally limited to a simple scale and polishing 
(93.1%). The extent and severity of periodontal 
disease were not exclusion criteria, since it was 
sought to evaluate this relationship in all types 
of chronic periodontitis.
The lack of a universally agreed definition of 
periodontal disease hampers the comparison 
of the existing studies. On the other hand, there 
is no single variable that entirely expresses the 
full complexity of the phenomenon of periodon-
tal disease progression and that justifies our 
analysis on more than one parameter. The aver-
age attachment loss gives an indication of the 
severity of the disease, while the number of 
teeth with pockets gives an idea of the extent 
of it, however, we must not forget that the 
attachment loss, considered the “gold stand-
ard” in the diagnosis of periodontal disease, is 
a measure of its past evolution.
The control group presented a greater plaque 
score (P < 0.01), however, the amount of visible 
calculi was similar in both groups. It is some-
what curious the difference found on plaque 
score, since no significant differences were 
found on oral hygiene habits reported by sub-
jects in both groups. This may be due to a ten-
dency to omit behaviours considered less 
appropriate.
The attachment loss was slightly higher in the 
study group (4.31 ± 1.08 vs. 4.05 ± 1.28), 
although the difference is not significant. Since 
the mean values of probing depth are similar, 
this difference can be attributed to the fact that 
the study group had a greater tendency for gin-
gival recession (1.06 ± 0.81 vs. 0.78 ± 0.70). 
However is important to note that gingival 
recession may be associated with other causes 
beyond periodontal disease. In the remaining 
periodontal parameters, there are no signifi-
cant differences indicating a greater extent or 
severity of the disease in the study group. In 
contrast, other authors have observed an asso-
ciation between menopausal status and attach-
ment loss. In a study of 46 menopausal women 
and 15 premenopausal, Pallos et al. observed 
significant differences in attachment loss and 
alveolar bone loss. Still, when comparing oes-
trogen sufficient menopausal women and oes-
trogen deficient women for the same parame-
ters, no significant differences were found [33].
When comparing results from different studies 
it is important to consider the age of the stud-
ied populations. In our study, the mean age of 
participants was 61.2 ± 8.0 years. Results 
from studies in younger populations typically 
revealed negative results since it is unlikely to 
find a significant degree of disease (osteoporo-
sis or periodontal) at these ages. On the other 
hand, the fact that the majority of patients in 
our study have a high BMI, may contribute to 
increased peripheral conversion of estrogens, 
providing a protective effect difficult to es- 
timate.
Some studies observed an increased teeth 
retention [14, 15], reduction of gingival inflam-
mation, and reduction of attachment loss in 
women on HRT treatment, suggesting a protec-
tive role of estrogens in periodontal disease 
progression [12, 13, 34, 35]. We also conduct-
ed a comparison between women who used 
bisphosphonates or HRT and those who did not 
use (data not shown), but no statistically signifi-
cant differences were observed for periodontal 
parameters, probably due to the small number 
of users.
The fact that we have opted for a complete peri-
odontal examination, rather than a partial 
recording protocol and the fact that the meas-
urements were made by a single blinded exam-
iner are strong points of this study.
Regarding limitations, it is important to note 
that the determination of menopausal status 
and HRT use is based on anamnesis and sub-
ject to errors, however, it continues to be widely 
used, since the determination of hormone lev-
els is costly and time consuming. Moreover, an 
isolated measurement of hormone levels does 
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not reveal the oestrogen life exposure. Some 
studies show a high degree of concordance 
between self-reported data regarding the use 
of HRT and medical records [14].
Since the study population is not representa-
tive of the Portuguese population, this data 
should not be extrapolated to the general popu-
lation. It is possible that the methodology used 
tended to accrue individuals more concerned 
with their health and with easier access to 
health care system. Thus, additional studies 
with larger samples and longer periods of 
observation are needed in order to confirm or 
exclude the role of menopause on periodontal 
disease course.
Conclusions
When comparing pre and postmenopausal 
women we did not observe significant differ-
ences for periodontal parameters and teeth 
loss.
The relationship between menopause and peri-
odontal disease is difficult to establish due to 
the multitude of factors involved. If any relation-
ship is found, it will always be less significant 
comparing to other well-known risk factors of 
periodontal disease.
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